CCN2 and triple-negative breast carcinoma: MMP3 overexpression enhanced CCN2/CTGF promoter activity in the human chondrosarcoma-derived chondrocytic cell line HCS-2/8 and non-basal type, triple-negative breast cancer cell line MDA-MB-231 [28].